drugset / Trial / NCT02991261

Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers

NCT02991261

Phase 1 Completed 24 enrolled Sun Pharma Advanced Research Company Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of the study is to determine the relative bioavailability, safety and tolerability of SPARC001 and Reference001 in healthy, adult, male and female subjects

Timeline

Start
2017-02-06
Primary completion
2017-03-15
Completion
2017-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocodone Unknown
Subject SPARC001 Unknown

Indications

No indication recorded.